Private Limited Company

FOCUS PHARMACEUTICALS LIMITED

ActiveCompany 04522142United Kingdom
Bulk record snapshot1 OCT 2026Source details →

Registered office

DASHWOOD HOUSE, 69 OLD BROAD STREET, LONDON, UNITED KINGDOM, EC2M 1QS
Incorporated30 August 2002
Company age24 years

TXT In plain English

Company description

BritDB description

FOCUS PHARMACEUTICALS LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 30 August 2002; registered for 24 years; registered office reported in LONDON, UNITED KINGDOM. Its primary declared activity is 21200 · Manufacture of pharmaceutical preparations, with 2 additional SIC activities reported.

This BritDB profile also contains linked public records: 5 PSC records, 24 trade marks, 3 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.

Prepared from public dataChecked 10 October 2026 · 10 profile sources connected
How this description is built →
i

Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.

01 Company overview

Identity and registration

Snapshot 1 October 2026
Official name
FOCUS PHARMACEUTICALS LIMITED
Company number
04522142
Company type
Private Limited Company
Status
Active
Country of origin
United Kingdom
Dissolution date
Not supplied
Accounts category
FULL
Mortgage charges
9 total · 0 outstanding · 9 satisfied
Limited partnership members
0 general · 0 limited
i

A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.

02 Filing dates

Accounts and statements

Companies House
AccountsBulk record

Last accounts made up to

31 December 2025

Next accounts due

30 September 2027
Confirmation statementBulk record

Last statement made up to

27 July 2026

Next statement due

10 August 2027
Filing source and official link →

BritDB does not infer overdue status when the source does not state it.

03 Supplier payments

Payment practices and performance

Period to 31 December 2018
Average time to pay37.0 days
Paid within 30 days49.0%
Paid after 60 days6.0%
Not paid within terms54.0%
Reporting period
1 July 2018 – 31 December 2018
Filed
28 January 2019
Shortest standard term
30 days
Longest standard term
60 days
E-invoicing offered
No
Supply-chain finance
Not offered
Payment codes
No
Construction retentions
No qualifying construction contracts
Complete reported payment fields
Policy regime
Regime-1
Financial period started
Not supplied
Qualifying contracts
Yes
Payments made
Yes
Invoice value paid outside agreed terms
£0
Invoices paid in 31–60 days
45.0%
Invoices unpaid due to dispute
0.0%
Maximum contractual payment period
60 days
Supplier-list charging policy
No
Supplier-list charges made
No

Maximum contractual payment information

The maximum contractual payment period (in days) - The maximum contractual payment terms for Intercompany Vendors is "180 days from the date of Invoice", for Vendors other than Intercompany vendors, the maximum contractual term is "30 days end of the following month"

Reported terms and dispute process
  1. Standard payment terms

    The Company follows a standard payment terms of "30 days end of the following month, in which the invoice is received". For Intercompany Vendor's the standard terms are "180 days from the date of invoice"

  2. Dispute resolution process

    In case of any invoice disputes, the relevant department within the company availing the services is informed by email. The relevant department would then inform the vendor via email/phone of the nature of dispute and get it resolved.
    In case of disputes relating to services, the relevant department before approving the costs would inform the Vendor over an email. In case the invoice is considered to be correct, the same is internally approved and paid.
    For minor invoice errors, the Finance department may send an email directly to the relevant finance contact on Vendor side.

Earlier payment reports (1 shown)
  1. 35.0 average days to pay76.0% outside terms
i

This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.

04 Supply-chain transparency

Modern slavery statement

Statement year 2021
Organisation
FOCUS PHARMACEUTICALS LIMITED
Group submission
Yes
Parent organisation
ADVANZ PHARMA SERVICES (UK) LIMITED
Statement period
1 January 2020 – 31 December 2020
Approved
14 May 2021
Sectors
Healthcare and pharmaceuticals
✓

Organisation structure

Covered in the statement

✓

Policies

Covered in the statement

✓

Risk assessment

Covered in the statement

✓

Due diligence

Covered in the statement

✓

Training

Covered in the statement

✓

Goals and KPIs

Covered in the statement

Full statement information supplied to the registry
Reported turnover band
£100 million to £500 million
Years producing statements
1 to 5 years
ILO indicators included
Not answered
Registry record updated
28 July 2021

Policies described

Freedom of workers to terminate employment Prohibits any threat of violence, harassment and intimidation Prohibits child labour Prohibits discrimination

Training described

Your whole organisation

Worker engagement and working conditions

Your suppliers Professional auditors Workers within your organisation Workers within your supply chain

Grievance mechanisms

Using anonymous whistleblowing services, such as a helpline or mobile phone app

Other monitoring

We have a contractual right to visit the facilities of our Suppliers and Manufacturers to control the way they operate (including the working conditions across their operations).

Demonstrated progress

We take a range of measures to monitor the effectiveness of the steps that we are taking to ensure that slavery and/or human trafficking is not taking place within our business or Partners. We are committed to continuously improving the way we manages our business operations. As part of this commitment we will continue to review and improve our policies, processes and controls to ensure that modern slavery does not take place in any of our supply chains or our own business.

Reported risks and mitigations

  • Risk: Global business activities in multiple locations and jurisdictions with various approaches regarding modern slavery.
  • Area: Within your supply chains
  • Tier: Tier 1 suppliers Tier 2 suppliers Tier 3 suppliers and below
  • Group: Migrants Refugees Children
  • Location: India
  • Mitigation: ADVANZ PHARMA has implemented a “Standards for Product Manufacturers and Suppliers” Policy that sets forth ADVANZ PHARMA standards and requirements for all its Manufacturers and Suppliers in the areas of ethics, labor rights, health and safety, environmental and human rights practices. In addition we require from any new business partner to complete and sign an Anti-Corruption and Modern Slavery Declaration and to comply with all the mentioned requirements.
  • Risk: Business interactions with a large scale of third party vendors, including distributors, suppliers, manufacturers which means that compliance with applicable Human rights laws is harder to control.
  • Risk: Operational entities in several locations and jurisdictions with a decentralised management structure which increases the difficulty to monitor and control staff behaviour.
  • Area: Within your own operations
  • Group: Migrants Children
  • Mitigation: We have implemented a robust Compliance programme within the Group including policies, control processes and trainings, In addition we are conducting internal and external audits on a yearly basis to control and monitor our worlwide activities.
i

A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.

05 Public procurement

Contracts Finder awards

Exact GB-COH links
active · 30 November 2021

NHS National Generic Pharmaceuticals Wave 13

ATAMIS LTD · ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be

Supplier named in award
FOCUS PHARMACEUTICALS LIMITED
Award value
£1
Contract period
1 February 2022 – 31 May 2024
Published
3 August 2022
Procedure
Open procedure (below threshold)
Main CPV
33600000
Source release ID
ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be-2022-08-03T08:38:18+01:00
active · 1 May 2019

NHS Framework Agreement for Branded Medicines - National

NHS England · ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7

Supplier named in award
Focus Pharmaceuticals Ltd
Award value
£1,351,341,890
Contract period
1 May 2019 – 30 April 2021
Published
9 August 2019
Procedure
Open procedure (above threshold)
Main CPV
33600000
Source release ID
ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7-2019-08-09T15:57:38+01:00
i

The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.

TM UK trade marks

Exact owner-name matches

24 records
Registered · UK00003046437

FOCUS PHARMA

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
12 March 2014
Valid until / renewal due
12 March 2024
Open BritTM →
Registered · UK00002644761

FOCAZIN

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
5 December 2012
Valid until / renewal due
5 December 2022
Open BritTM →
Registered · UK00002644763

FOBRUPRO

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
5 December 2012
Valid until / renewal due
5 December 2022
Open BritTM →
Registered · UK00002644767

FOXYNIN

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
5 December 2012
Valid until / renewal due
5 December 2022
Open BritTM →
Registered · UK00002644523

FOCAMOL

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
4 December 2012
Valid until / renewal due
4 December 2022
Open BritTM →
Registered · UK00002644553

FOCATIN

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
4 December 2012
Valid until / renewal due
4 December 2022
Open BritTM →
Registered · UK00002616575

MEMEXO

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
3 April 2012
Valid until / renewal due
3 April 2022
Open BritTM →
Registered · UK00002616577

GLIDIA

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
3 April 2012
Valid until / renewal due
3 April 2022
Open BritTM →
Registered · UK00002423278

VOLEZE

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
1 June 2006
Valid until / renewal due
1 June 2026
Open BritTM →
Registered · UK00002423279

CLOMOVATE

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
1 June 2006
Valid until / renewal due
1 June 2026
Open BritTM →
Registered · UK00002423280

OROEZE

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
1 June 2006
Valid until / renewal due
1 June 2026
Open BritTM →
Registered · UK00002423348

MALYCE

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
1 June 2006
Valid until / renewal due
1 June 2026
Open BritTM →
Registered · UK00002401301

ADANIF

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
12 September 2005
Valid until / renewal due
12 September 2025
Open BritTM →
Registered · UK00002401302

ADACIUM

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
12 September 2005
Valid until / renewal due
12 September 2025
Open BritTM →
Registered · UK00002377374

METMAX

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
5 November 2004
Valid until / renewal due
5 November 2024
Open BritTM →
Registered · UK00002377375

NOLYCE

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
5 November 2004
Valid until / renewal due
5 November 2024
Open BritTM →
Registered · UK00002377376

BENZYFLAM

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
5 November 2004
Valid until / renewal due
5 November 2024
Open BritTM →
Registered · UK00002377377

FOCUS PHARMACEUTICALS

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
5 November 2004
Valid until / renewal due
5 November 2024
Open BritTM →
Registered · UK00002346703

STERI-HALE

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
22 October 2003
Valid until / renewal due
22 October 2023
Open BritTM →
Registered · UK00002346705

STERI-RESP

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
22 October 2003
Valid until / renewal due
22 October 2023
Open BritTM →
Registered · UK00002346709

ALFATRAL

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
22 October 2003
Valid until / renewal due
22 October 2023
Open BritTM →
Registered · UK00002346710

SERTRATAB

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
22 October 2003
Valid until / renewal due
22 October 2023
Open BritTM →
Registered · UK00002346712

TRIPRIL

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
22 October 2003
Valid until / renewal due
22 October 2023
Open BritTM →
Withdrawn · UK00002616573

ERIVEX

Owner Focus Pharmaceuticals Limited · classes 5

Filed / designated
3 April 2012
Valid until / renewal due
Not supplied
Open BritTM →
!

This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.

06 Ownership and control

People with significant control

Snapshot 10 October 2026
Current records1
Ceased records4
PSC source and official link →
Corporate entityCurrent

Mercury Pharma Group Limited

  • Owns 75% or more of shares
  • Controls 75% or more of voting rights
  • Can appoint or remove directors
Country registered
United Kingdom
Legal authority
Companies Act 2006
Legal form
Private Limited Company
Place registered
Companies House
Registration number
02330913
Notified
16 December 2021
Corporate entityCeased

Focus Pharma Holdings Limited

  • Owns 75% or more of shares
  • Controls 75% or more of voting rights
  • Can appoint or remove directors
Country registered
United Kingdom
Legal authority
Companies Act 2006
Legal form
Private Limited Company
Place registered
Companies House
Registration number
06317129
Notified
1 June 2021
Ceased
16 December 2021
Corporate entityCeased

The Blackstone Group Inc.

  • Owns 25% to 50% of shares
  • Controls 25% to 50% of voting rights
Country registered
Delaware
Legal authority
Delaware
Legal form
Corporation
Place registered
Delaware Secretary Of State
Registration number
4315990
Notified
27 March 2020
Ceased
1 June 2021
Corporate entityCeased

Focus Pharma Holdings Limited

  • Owns 75% or more of shares
  • Controls 75% or more of voting rights
  • Can appoint or remove directors
Country registered
United Kingdom
Legal authority
England And Wales
Legal form
Private Limited Company
Place registered
Uk Companies House
Registration number
06317129
Notified
10 August 2018
Ceased
27 March 2020
PSC statementCeased

No individual or entity with signficant control

Notified
27 July 2016
Ceased
10 August 2018
i

PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.

07 Charity register

Charity Commission links

Snapshot 29 September 2026
CCEW

No exact company-number link in this snapshot

The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.

i

This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.

08 Northern Ireland charity register

CCNI exact company links

Snapshot 29 September 2026
CCNI

No unambiguous company-number link found

The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.

i

CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.

09 Sanctions screening

UK Sanctions List

Report 8 October 2026
UKSL

No exact business-registration-number link found

The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.

!

No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.

10 Public procurement

Find a Tender links

Snapshot 29 September 2026
i

These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.

11 Environmental register

Environment Agency waste registrations

Snapshot 29 September 2026
EA

No exact company-number registration linked

The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.

i

This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.

12 Nature of business

Standard Industrial Classification

SIC 2007
46460

Wholesale of pharmaceutical goods

72190

Other research and experimental development on natural sciences and engineering

13 Connected public record

Checks beyond the company register

Partial coverage
CCEW

Charity Commission

0 exact company-number links.

Checked
CCNI

Northern Ireland charities

0 unambiguous company-number links.

Checked
FTS

Public contracts

1 procurement process linked by exact GB-COH identifier.

Checked
EA

Waste register

0 exact company-number registrations.

Checked
GZ

Corporate notices

The Gazette is not yet connected.

Not checked
UKSL

UK Sanctions List

No exact business-registration-number link in this report.

Checked
!

A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.

14 Record timeline

Dates in the bulk record

4 events
  1. Detected change

    Accounts due date: 2026-09-30 → 2027-09-30

  2. Confirmation statement

    Latest confirmation statement made up to this date

  3. Accounts

    Latest accounts made up to this date

  4. Incorporation

    Company incorporated

15 Provenance

Sources for this profile

10 sources

Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.